Zaslat SMS: PREVALENCE AND FACTORS RELATED TO PUBLIC INJECTING IN OTTAWA, CANADA: IMPLICATIONS FOR THE DEVELOPMENT OF A TRIAL SAFER INJECTING FACILITY